analytics_image
Access TOC - Artificial Intelligence in Drug Discovery Market 2025\
Vantage Market Research
Vantage Market Research

Reports - Artificial Intelligence in Drug Discovery Market

iconHealthcare

Artificial Intelligence in Drug Discovery Market

Artificial Intelligence in Drug Discovery Market Size | Industry Report, 2035 by Application (Drug Optimization and Repurposing, Preclinical Testing, Others), by Therapeutic Look (Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases), by Region (North America, Latin America, Europe, Asia Pacific

ppt icon
pdf icon
xlsx icon
power bi icon
immediate delivery icon

Industry Leaders Trust Us For Actionable Intelligence

Table of Contents

Chapter 1   Executive Dashboard
1. Strategic Imperatives
Chapter 2   Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3   Global Artificial Intelligence in Drug Discovery Market - Segment Analysis
1. Overview
2. Global Artificial Intelligence in Drug Discovery Market, 2019 - 2030 (USD Million)
3. Global Artificial Intelligence in Drug Discovery Market - by Application
3.1. By Drug Optimization and Repurposing
3.2. By Preclinical Testing
3.3. By Others
4. Global Artificial Intelligence in Drug Discovery Market - by Therapeutic Look
4.1. By Oncology
4.2. By Neurodegenerative Diseases
4.3. By Cardiovascular Disease
4.4. By Metabolic Diseases
4.5. By Infectious Disease
4.6. By Others
5. Global Artificial Intelligence in Drug Discovery Market - by region
5.1. North America
5.2. Europe
5.3. Asia Pacific
5.4. Latin America
5.5. Middle East & Africa
6. Market comparative analysis
Chapter 4   North America Artificial Intelligence in Drug Discovery Market - Segment Analysis
1. Overview
2. North America Artificial Intelligence in Drug Discovery Market, 2019 - 2030 (USD Million)
3. North America Artificial Intelligence in Drug Discovery Market - by Application
3.1. By Drug Optimization and Repurposing
3.2. By Preclinical Testing
3.3. By Others
4. North America Artificial Intelligence in Drug Discovery Market - by Therapeutic Look
4.1. By Oncology
4.2. By Neurodegenerative Diseases
4.3. By Cardiovascular Disease
4.4. By Metabolic Diseases
4.5. By Infectious Disease
4.6. By Others
Chapter 5   Europe Artificial Intelligence in Drug Discovery Market - Segment Analysis
1. Overview
2. Europe Artificial Intelligence in Drug Discovery Market, 2019 - 2030 (USD Million)
3. Europe Artificial Intelligence in Drug Discovery Market - by Application
3.1. By Drug Optimization and Repurposing
3.2. By Preclinical Testing
3.3. By Others
4. Europe Artificial Intelligence in Drug Discovery Market - by Therapeutic Look
4.1. By Oncology
4.2. By Neurodegenerative Diseases
4.3. By Cardiovascular Disease
4.4. By Metabolic Diseases
4.5. By Infectious Disease
4.6. By Others
Chapter 6   Asia Pacific Artificial Intelligence in Drug Discovery Market - Segment Analysis
1. Overview
2. Asia Pacific Artificial Intelligence in Drug Discovery Market, 2019 - 2030 (USD Million)
3. Asia Pacific Artificial Intelligence in Drug Discovery Market - by Application
3.1. By Drug Optimization and Repurposing
3.2. By Preclinical Testing
3.3. By Others
4. Asia Pacific Artificial Intelligence in Drug Discovery Market - by Therapeutic Look
4.1. By Oncology
4.2. By Neurodegenerative Diseases
4.3. By Cardiovascular Disease
4.4. By Metabolic Diseases
4.5. By Infectious Disease
4.6. By Others
Chapter 7   Latin America Artificial Intelligence in Drug Discovery Market - Segment Analysis
1. Overview
2. Latin America Artificial Intelligence in Drug Discovery Market, 2019 - 2030 (USD Million)
3. Latin America Artificial Intelligence in Drug Discovery Market - by Application
3.1. By Drug Optimization and Repurposing
3.2. By Preclinical Testing
3.3. By Others
4. Latin America Artificial Intelligence in Drug Discovery Market - by Therapeutic Look
4.1. By Oncology
4.2. By Neurodegenerative Diseases
4.3. By Cardiovascular Disease
4.4. By Metabolic Diseases
4.5. By Infectious Disease
4.6. By Others
Chapter 8   Middle East & Africa Artificial Intelligence in Drug Discovery Market - Segment Analysis
1. Overview
2. Middle East & Africa Artificial Intelligence in Drug Discovery Market, 2019 - 2030 (USD Million)
3. Middle East & Africa Artificial Intelligence in Drug Discovery Market - by Application
3.1. By Drug Optimization and Repurposing
3.2. By Preclinical Testing
3.3. By Others
4. Middle East & Africa Artificial Intelligence in Drug Discovery Market - by Therapeutic Look
4.1. By Oncology
4.2. By Neurodegenerative Diseases
4.3. By Cardiovascular Disease
4.4. By Metabolic Diseases
4.5. By Infectious Disease
4.6. By Others
Chapter 9   Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10   COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11   Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12   Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13   Company Profiles
1. IBM Corporation (US)
2. Microsoft (US)
3. and Google (US)
4. NVIDIA Corporation (US)
5. Atomwise Inc. (US)
6. Deep Genomics (Canada)
7. Cloud Pharmaceuticals (US)
8. Insilico Medicine (US)
9. BenevolentAI (UK)
10. Exscientia (UK)
11. Cyclica (Canada)
12. BIOAGE (US)
13. Numerate (US)
14. NuMedii (US)
15. Envisagenics (US)
16. twoXAR (US)
17. OWKIN Inc. (US)
18. XtalPi (US)
19. Verge Genomics (US)
20. and BERG LLC (US)
Chapter 14   Key Primary Respondents - VERBATIM
Chapter 15   Discussion Guide
Chapter 16   Customization Offered
Chapter 17   Annexure
Chapter 18   List of Figures
Chapter 19   List of Tables
Chapter 20   List of Abbreviations

FAQ‘s

vantage logo

Vantage Market Research & Consultancy Services is all about providing accurate and reliable market intelligence to its clients for the seamless execution of their business growth strategies.

© 2025 Vantage Market Research. All right reserved
Secured Bysecured by